Counteracting methicillin resistant Staphylococcus aureus through novel Citral-Azithromycin combination

Nature·Jul 15

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Researchers are exploring various combinations of antimicrobial agents to counteract methicillin-resistant Staphylococcus aureus. Different studies are investigating the effectiveness of pairing certain compounds, such as citral and azithromycin, as well as other novel combinations, against MRSA strains. The approaches being investigated include synergistic combinations of existing antibiotics and newly discovered compounds with potential antibacterial properties.

Full coverage

Standard Treatment Workflows: scaling system-compatible approaches to rational antibiotic use

Frontiers·Apr 7

Restoration of Oxacillin susceptibility in MRSA strains by NPPB

Nature·Jul 3

Proteomic response of methicillin-resistant S. aureus to a synergistic antibacterial drug combination: a novel erythromycin derivative and oxacillin

Nature·Jan 25

In vitro activity of fosfomycin in combination with linezolid against clinical isolates of methicillin-resistant Staphylococcus aureus

Nature·Feb 12

Synergistic combination of two antimicrobial agents closing each other’s mutant selection windows to prevent antimicrobial resistance

Nature·May 8

Novel long-chain compounds with both immunomodulatory and MenA inhibitory activities against Staphylococcus aureus and its biofilm

Nature·Jan 10

Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. I. The taxonomy of the producing strain, and the fermentation, isolation and antibacterial activities

Nature·Mar 15

Gut-derived cinnamic acid limits allergic airway inflammation via the SAT1-spermidine-eIF5A hypusination axis

Nature·Jul 7

View original report at Nature ↗

Fetching the latest headlines…